01 enero 2015

JOURNAL OF VASCULAR SURGERY. The Abdominal Aortic Aneurysm Statistically Corrected Operative Risk Evaluation (AAA SCORE) for predicting mortality after open and endovascular interventions

Graeme K. Ambler, MB BChir, BSc, PhD, MRCS, Manjit S. Gohel, MD, FRCS, FEBVS, David C. Mitchell, MA, MB BS, MS, FRCS, Ian M. Loftus, BSc, MB ChB, MD, FRCS, Jonathan R. Boyle, MB ChB, MD, MA, FRCS in association with the Audit and Quality Improvement Committee of the Vascular Society of Great Britain and Ireland

Background: Accurate adjustment of surgical outcome data for risk is vital in an era of surgeon-level reporting. Current risk prediction models for abdominal aortic aneurysm (AAA) repair are suboptimal. We aimed to develop a reliable risk model for in-hospital mortality after intervention for AAA, using rigorous contemporary statistical techniques to handle missing data.

01 enero 2015

JOURNAL OF VASCULAR SURGERY. Costs of repair of abdominal aortic aneurysm with different devices in a multicenter randomized trial

Jon S. Matsumura, MD, Kevin T. Stroupe, PhD, Frank A. Lederle, MD, Tassos C. Kyriakides, PhD, Ling Ge, MS, Julie A. Freischlag, MD for the Open Versus Endovascular Repair (OVER) Veterans Affairs Cooperative Study Group ( Erika R. Ketteler, MD, Darra D. Kingsley, MD, John M. Marek, MD, Richard J. Massen, MD, Brian D. Matteson, MD, J. David Pitcher, MD, Mark Langsfeld, MD, John D. Corson, MD, James M. Goff Jr., MD, Karthnik Kasirajan, MD, Christina Paap, RN, Diane C. Robertson, RN, Atef Salam, MD, Ravi Veeraswamy, MD, Ross Milner, MD, Karthikeshwar Kasirajan, MD, Jane Guidot, RN, Brajesh K. Lal, MD, Steven J. Busuttil, MD, Michael P. Lilly, MD, Melita Braganza, Kea Ellis, RN, Mark A. Patterson, MD, William D. Jordan, MD, David Whitley, MD, Steve Taylor, MD, Marc Passman, MD, Donna Kerns, RN, Cindy Inman, RN, Jennifer Poirier, RN, James Ebaugh, MD, Joseph Raffetto, MD, David Chew, MD, Subhash Lathi, MD, Christopher Owens, MD, Kathleen Hickson, RN, Hasan H. Dosluoglu, MD, Karen Eschberger, RN, Melina R. Kibbe, MD, Henry M. Baraniewski, MD, Jon Matsumura, MD, Michelle Endo, Anna Busman, RN, Wendy Meadows, RN, Mary Evans, RN, Joseph S. Giglia, MD, Hosam El Sayed, MD, Amy B. Reed, MD, Madeline Ruf, RN, Stephanie Ross, RN, Jessie M. Jean-Claude, MD, Gilles Pinault, MD, Preet Kang, MD, Nadine White, RN, Matthew Eiseman, RN, Reba Jones, RN, Carlos H. Timaran, MD, J. Gregory Modrall, MD, M. Burress Welborn III, MD, Jorge Lopez, MD, Tammy Nguyen, MT (ASCP), John K.Y. Chacko, MD, Kenneth Granke, MD, Angela G. Vouyouka, MD, Erin Olgren, Prakash Chand, MD, Brenda Allende, Michael Ranella, Claudia Yales, RN, Thomas A. Whitehill, MD, William C. Krupski, MD, Mark R. Nehler, MD, Stephen P. Johnson, MD, Darrell N. Jones, PhD, Pamela Strecker, RN, Michelle A. Bhola, RN, Cynthia K. Shortell, MD, John L. Gray, MD, Jeffrey H. Lawson, MD, Richard McCann, MD, Mark W. Sebastian, MD, Jean Kistler Tetterton, NP, Carla Blackwell, RN, Patricia A. Prinzo, BS, Nina Lee, RN, Frank T. Padberg Jr., MD, Joaquim J. Cerveira, MD, Brajesh K. Lal, MD, Robert W. Zickler, MD, Karen A. Hauck, RN, Scott A. Berceli, MD, W. Anthony Lee, MD, C. Keith Ozaki, MD, Peter R. Nelson, MD, Anne S. Irwin, RN, Randy Baum, RN, Bernadette Aulivola, MD, Heron Rodriguez, MD, Fred N. Littooy, MD, Howard Greisler, MD, Mary T. O´Sullivan, RN, Panagiotis Kougias, MD, Peter H. Lin, MD, Ruth L. Bush, MD, Gene Guinn, MD, Catherine Cagiannos, MD, Sherilyn Pillack, RN, Barbara Guillory, RN, Dolores Cikrit, MD, Stephen G. Lalka, MD, Gary Lemmon, MD, Ryan Nachreiner, MD, Mitzi Rusomaroff, RN, Elaine O´Brien, RN, Joseph J. Cullen, MD, Jamal Hoballah, MD, W. John Sharp, MD, Jeanne L. McCandless, RN, Vickie Beach, RN, David Minion, MD, Thomas H. Schwarcz, MD, Joy Kimbrough, RN, Laura Ashe, Anna Rockich, MS, Jill Warner-Carpenter, RN, Mohammed Moursi, MD, John F. Eidt, MD, Sandra Brock, RN, Christian Bianchi, MD, Vicki Bishop, RN, Ian L. Gordon, MD, Roy Fujitani, MD, Stephen M. Kubaska III, MD, Mina Behdad, MD, Reza Azadegan, MD, Christine Ma Agas, MPH, Kathy Zalecki, John R. Hoch, MD, Sandra C. Carr, MD, Charles Acher, MD, Margaret Schwarze, MD, Girma Tefera, MD, Matthew Mell, MD, Beth Dunlap, RN, Janice Rieder, RN, John M. Stuart, MD, Darryl S. Weiman, MD, Omran Abul-Khoudoud, MD, H. Edward Garrett, MD, Sandra M. Walsh, MA, Karen L. Wilson, RN, Gary R. Seabrook, MD, Robert A. Cambria, MD, Kellie R. Brown, MD, Brian D. Lewis, MD, Susan Framberg, RN, Christa Kallio, RN, Roderick A. Barke, MD, Steven M. Santilli, MD, Alexandre C. d´Audiffret, MD, Nancy Oberle, RN, Catherine Proebstle, NP, Lauri Lee Johnson, RN, Glenn R. Jacobowitz, MD, Neal Cayne, MD, Caron Rockman, MD, Mark Adelman, MD, Paul Gagne, MD, Matthew Nalbandian, MD, Leah J. Caropolo, BS, Iraklis I. Pipinos, MD, Jason Johanning, MD, Thomas Lynch, MD, Holly DeSpiegelaere, RN, Georgia Purviance, RN, Wei Zhou, MD, Ronald Dalman, MD, Jason T. Lee, MD, Bassem Safadi, MD, Sheila M. Coogan, MD, Sherry M. Wren, MD, Doghdoo D. Bahmani, Deanna Maples, NP, Shawna Thunen, RN, Michael A. Golden, MD, Marc E. Mitchell, MD, Ronald Fairman, MD, Sally Reinhardt, RN, Mark A. Wilson, MD, Edith Tzeng, MD, Satish Muluk, MD, Nina M. Peterson, RN, Maria Foster, RN, James Edwards, MD, Gregory L. Moneta, MD, Gregory Landry, MD, Lloyd Taylor, MD, Richard Yeager, MD, Eleanor Cannady, RN, Gerald Treiman, MD, Stephanie Hatton-Ward, RN, Barbara Salabsky, RN, Nikhil Kansal, MD, Erik Owens, MD, Melanie Estes, RN, Beth A. Forbes, RN, Cinda Sobotta, RN, Joseph H. Rapp, MD, Linda M. Reilly, MD, Sandra L. Perez, NP, Kimberly Yan, Rajaabrata Sarkar, MD, Shelley S. Dwyer, RN, Ted R. Kohler, MD, Thomas S. Hatsukami, MD, David G. Glickerman, MD, Michael Sobel, MD, Thomas S. Burdick, MD, Kimberly Pedersen, RN, Patricia Cleary, NP, Nikhil Kansal, MD, Erik Owens, MD, Melanie Estes, RN, Beth A. Forbes, RN, Cinda Sobotta, RN, Martin Back, MD, Dennis Bandyk, MD, Brad Johnson, MD, Murray Shames, MD, Rebecca L. Reinhard, RN, Sandra C. Thomas, RN, Glenn C. Hunter, MD, Luis R. Leon Jr., MD, Alex Westerband, MD, Robert J. Guerra, MD, Macario Riveros, MD, John L. Mills Sr., MD, John D. Hughes, MD, Andrea M. Escalante, RN, Shemuel B. Psalms, Nancy N. Day, RN, Robyn Macsata, MD, Anton Sidawy, MD, Jonathan Weiswasser, MD, Subodh Arora, MD, Brenda J. Jasper, M ED, Alan Dardik, MD, Vivian Gahtan, MD, Bart E. Muhs, MD, Bauer E. Sumpio, MD, Richard J. Gusberg, MD, Marcelo Spector, MD, Jeffrey Pollak, MD, John Aruny, MD, E. Lynne Kelly, MD, James Wong, MD, Penny Vasilas, RN, Carmelene Joncas, RN, Hugh A. Gelabert, MD, Christian DeVirgillio, MD, David A. Rigberg, MD, Loretta Cole, RN)

Objective Prior analysis in the Open vs Endovascular Repair Veterans Affairs (VA) Cooperative Study (CSP #498) demonstrated that survival, quality of life, and total health care costs are not significantly different between the open and endovascular methods of repair of abdominal aortic aneurysm. The device is a major cost of this method of repair, and the objective of this study was to evaluate the costs of the device, abdominal aortic aneurysm repair, and total health care costs when different endograft systems are selected for the endovascular repair (EVR). Within each selected system, EVR costs are compared with open repair costs.

01 enero 2015

JOURNAL OF VASCULAR SURGERY. Intentional left subclavian artery coverage during thoracic endovascular aortic repair for traumatic aortic injury

Cameron L. McBride, BS, Joseph J. Dubose, MD, Charles C. Miller III, PhD, Alexa P. Perlick, Kristofer M. Charlton-Ouw, MD, Anthony L. Estrera, MD, Hazim J. Safi, MD, Ali Azizzadeh,

Background: Thoracic endovascular aortic repair (TEVAR) is widely used for treatment of traumatic aortic injury (TAI). Stent graft coverage of the left subclavian artery (LSA) may be required in up to 40% of patients. We evaluated the long-term effects of intentional LSA coverage (LSAC) on symptoms and return to normal activity in TAI patients compared with a similarly treated group whose LSA was uncovered (LSAU).

01 enero 2015

JOURNAL OF VASCULAR SURGERY. Upper extremity access for fenestrated endovascular aortic aneurysm repair is not associated with increased morbidity

Martyn Knowles, MD, David A. Nation, MD, David E. Timaran, MD, Luis F. Gomez, MD, M. Shadman Baig, MD, R. James Valentine, MD, Carlos H. Timaran,

Objective Fenestrated endovascular aortic aneurysm repair (FEVAR) is an alternative to open repair in patients with complex abdominal aortic aneurysms who are neither fit nor suitable for standard open or endovascular repair. Chimney and snorkel grafts are other endovascular alternatives but frequently require bilateral upper extremity access that has been associated with a 3% to 10% risk of stroke. However, upper extremity access is also frequently required for FEVAR because of the caudal orientation of the visceral vessels. The purpose of this study was to assess the use of upper extremity access for FEVAR and the associated morbidity.

01 enero 2015

JOURNAL OF VASCULAR SURGERY. Clinical outcomes of different approaches to aortic arch disease

Arudo Hiraoka, MD, Genta Chikazawa, MD, PhD, Kentaro Tamura, MD, Toshinori Totsugawa, MD, PhD, Taichi Sakaguchi, MD, PhD, Hidenori Yoshitaka, MD, PhD

Objective: The aim of this study was to evaluate the midterm clinical outcomes of various approaches, including hybrid procedures, to aortic arch pathologies.

01 enero 2015

JOURNAL OF VASCULAR SURGERY. The role of atropine in carotid stenting of recurrent stenosis after eversion endarterectomy

Serdar Demirel, MD, Nicolas Attigah, MD, Hans Bruijnen, MD, Carola Wieker, MD, Dittmar Böckler, MD

Objective: The value of prophylactic atropine use during carotid artery stenting (CAS) in primary carotid stenosis to prevent procedural hemodynamic depression is well accepted. However, its impact in case of recurrent stenosis after eversion carotid endarterectomy (E-CEA), which is known to be associated with decreased baroreflex function due to discontinuation of the carotid sinus nerve, has not been investigated so far.

01 enero 2015

JOURNAL OF VASCULAR SURGERY. Carotid artery stenting has increased risk of external carotid artery occlusion compared with carotid endarterectomy

Kevin Brown, MD, Dina S. Itum, MD, Joshua Preiss, Yazan Duwayri, MD, Ravi K. Veeraswamy, MD, Atef Salam, MD, Thomas F. Dodson, MD, Luke P. Brewster

Objective: The external carotid artery (ECA) can be an important source of cerebral blood flow in cases of high-grade internal carotid artery stenosis or occlusion. However, the treatment of the ECA is fundamentally different between carotid endarterectomy (CEA) and carotid artery stenting (CAS). CEA is routinely associated with endarterectomy of the ECA, whereas CAS excludes the ECA from direct flow. We hypothesize that these differences make ECA occlusion more common after CAS. Further, the impact of CAS on blood flow into the ECA is interesting because the flow from the stent into the ECA is altered in a way that may promote local inflammation and may influence in-stent restenosis (ISR). Thus, our objective was to use our institutional database to identify whether CAS increased the rate of ECA occlusion and, if it did, whether ECA occlusion was associated with ISR.

01 enero 2015

JOURNAL OF VASCULAR SURGERY. Comparative effectiveness of endovascular versus surgical revascularization for acute lower extremity ischemia

Ashraf G. Taha, MD, Raphael M. Byrne, BA, Efthymios D. Avgerinos, MD, Luke K. Marone, MD, Michel S. Makaroun, MD, Rabih A. Chaer, MD, MSc

Objective: Thrombolysis and open surgical revascularization are current options for the treatment of acute limb ischemia (ALI). Despite the several randomized controlled trials comparing the two options, no single treatment can yet be recommended as a universal initial management of ALI. The purpose of this study was to evaluate contemporary endovascular and surgical revascularization for ALI.

21 octubre 2013

CIRCULATION. Epidemiology and Prevention. Sex Difference in Risk of Second but Not of First Venous Thrombosis

Rachel E.J. Roach, BSc; Willem M. Lijfering, MD, PhD; Frits R. Rosendaal, MD, PhD; Suzanne C. Cannegieter, MD, PhD; Saskia le Cessie, PhD

Background: The risk of recurrent venous thrombosis is 2-fold higher in men than in women. In contrast, no such sex difference in the risk of first venous thrombosis has been reported. We hypothesized that, for a first event, a risk difference between the sexes is masked by female exposure to reproductive factors (oral contraception, pregnancy/puerperium, and postmenopausal hormone therapy).

01 febrero 2015

ENDOVASCULAR TODAY. The MYNX ACE® Vascular Closure Device

Rajesh M. Dave, MD, FACC, FSCAI

With 100% clinical success during a prospective evaluation of early user experiences involving 206 cases performed in five United States hospitals, the next-generation MYNX ACE® Vascular Closure Device (VCD) (AccessClosure, Inc., a Cardinal Health Company) (Figure 1) demonstrated strong potential as a safe and reliable closure device (Table 1). In addition, the new device displayed the benefits of versatility and patient satisfaction in a diverse and challenging patient population.

01 febrero 2015

ENDOVASCULAR TODAY. Two Stick or Not Two Stick: Acute Thrombosis of Femoral-Femoral Bypass Graft Resulting in Critical Limb Ischemia

John A. Phillips, MD

Revascularization in a patient with inflow disease of a left-to-right femoral-femoral bypass utilizing multiple access locations.

01 febrero 2015

ENDOVASCULAR TODAY. IN.PACT SFA Trial and IN.PACT Global Study: Study Design and Clinical Data Overview

John R. Laird Jr, MD

Creating rigorous studies to produce meaningful data for use in everyday clinical practice.

01 febrero 2015

ENDOVASCULAR TODAY. Managing Complex Femoropopliteal Lesions

Thomas Zeller, MD; Aljoscha Rastan, MD; Roland Macharzina, MD; Ulrich Beschorner, MD; and Elias Noory, MD

The latest data demonstrating the benefit of including drug-coated balloons in the interventionist’s toolbox.

01 febrero 2015

ENDOVASCULAR TODAY. IN.PACT™ Admiral™ DCB Case Study

Gunnar Tepe, MD

The patient was a 62-year-old man who was a current smoker. He had a baseline ankle-brachial index of 0.73 and a Rutherford category of 3. His preprocedure reference vessel diameter was 4.86 mm.

01 febrero 2015

ENDOVASCULAR TODAY. DCB Use in the Real World

Peter A. Schneider, MD; Prakash Krishnan, MD; Jos C. van den Berg, MD, PhD; Gunnar Tepe, MD; Lawrence A. Garcia, MD; and Krishna Rocha-Singh, MD

A panel of experts discusses recommendations for optimizing outcomes when treating complex SFA and popliteal lesions with drug-coated balloon technology.